Corporate Support
Sitemap
Singapore

ShareInvestor.com

Mobile Edition
Mode - Streaming
Switch to Static Mode?

Price Highlight

Index Highlight

Chart
STI
3,124.9
-11.1 (-0.35%)

 

  • STI Straits Times Index
    3,124.9
    -11.1 (-0.35%)
     
  • KLCI FTSE Bursa Malaysia KLCI
    1,599.8
    -3.0 (-0.19%)
    Index delayed 15 minutes
  • HSI Hang Seng Index
    26,270.0
    38.5 (0.15%)
    Index delayed 15 minutes
  • SSE SSE Composite Index
    2,880.3
    0.3 (0.01%)
    Index delayed 15 minutes
  • N225 Nikkei 225
    20,618.6
    -58.7 (-0.28%)
    Index delayed 20 minutes
  • JCI Jakarta Composite Index
    6,262.3
    -33.4 (-0.53%)
    Index delayed 10 minutes
  • KOR KOSPI
    1,964.7
    4.4 (0.22%)
    Index delayed 20 minutes
  • XAO XAO
    6,572.6
    -54.8 (-0.83%)
     

SGX Market

Bursa Market

HKEx Market

SET Market

IDX Market

ASX Market

NYSE Market

NASDAQ Market

NYSE American Market

  • Volume: 563.4M
  • Value: 738.0M
  • Rise: 149
  • Fall: 129
  • Unch: 558

Intraday Market Ticker Help

Intraday Market Ticker
Time Name Type Price Vol
  • Top Active

  • Top Gainer

  • Top Loser

Top Counters
Name Last Change
ThaiBev0.925+0.035
YZJ Shipbldg SGD0.965-0.005
Spackman0.014-0.001
ESR-REIT0.520+0.010
Synagie0.169+0.009
Y Ventures0.102+0.009
Rex Intl0.078+0.002
HMI0.720-
Ascott Reit1.280-0.020
Ascendas-hTrust1.060+0.010

World Indices

World Indices
Name Last Change
Nasdaq 7,948.6 -54.2
HSI 26,270.0 +38.5
HSCEI 10,177.3 +44.5
Jakarta 6,261.1 -34.6
Nikkei 225 20,618.6 -58.6
SSE Comp 2,880.3 +0.3
Shanghai A 3,017.4 +0.3
Shanghai B 264.8 +0.2
PSE Comp 0.0
KOSPI 1,964.7 +4.4

Asian Indices delayed. US Indices updated twice daily at 7:30am and 7:30pm.

Fundamental - Factsheet

Help
  • Factsheet

  • Print

Eu Yan Sang EU YAN SANG INTERNATIONAL LTD
Quotes 10 Minutes Delayed. No Trades for The Day
Last (SGD): 0.600 Change: - High: - Remarks: DL
Remarks legend:
RemarksDescriptionRemarksDescription
SuspSuspendedIMMImmediate Delivery
PLPending ListingPAPending Announcement
DLDelistedCTConditional Trading
CWConditional When IssueWIWhen Issue
BIBuyIn OnlyJAdjust
HTrading HaltCDCum Dividend
XDEx DividendCBCum Bonus
XBEx BonusCRCum Rights
XREx RightsCOCum Offer
XOEx OfferCECum Entitlement
XEEx EntitlementCICum Interest
XIEx InterestCACum All
XAEx AllSCScripless Conversion
CIRBCircuit Breaker TriggeredCIRHHalt due to Circuit Breaker Triggered
Change (%): - Low: -
Open - Yesterday's Close 0.600
Buy Price - Sell Price -
Buy Volume ('000) - Sell Volume ('000) -
Cumulative Volume ('000) - Cumulative Value -
Click to show Stock Prices chart

Latest News

View All News

Key Statistics

EPS (SGD) a -0.03001 Trailing EPS (SGD) e -0.03001 NAV (SGD) b 0.2982
PE a - Trailing PE f - Price / NAV b 2.0121
Dividend (SGD) d - Cash In Hand (SGD) g 0.0634 Issued & Paid-up Shares c 449,190,000
Dividend Yield (%) d - Price / Cash In Hand g 9.464 Treasury Shares h -
Beta - 75 Daysi - R-Squared - 75 Days(%)i - Market Cap (M) 269.514
Beta - 500 Daysi - R-Squared - 500 Days (%)i - Enterprise Value (M) 269.514
Piotroski F Score - Exchange Code E02 Par Value ( SGD ) n.a.
52 Weeks Volatility (%) 6-Month VWAP n.a. Free Float (%) -
Under CPF Investment Scheme (CPFIS) No
Sector & Industry Pharmaceuticals: Generic
Category Classification Medical & Biotechnology / Retail
Notes:
  1. Based on latest Full Year results announcement, adjusted for the current number of shares.
  2. Based on latest results announcement (Full Year, Half Year or Interim), adjusted for carrying value of "Other Share Capital", illustrative financial effects of corporate actions (if applicable) and the current number of shares.
  3. Rounded to the nearest thousand. Updated on 30 Sep 2016.Please click here for more information.
  4. Dividend is based on latest Full Year results announcement, adjusted for current number of shares and excludes special dividend.
  5. Summation of the earnings from the latest 4 Quarter (or 2 Half Year) results announcement, adjusted for the current number of shares.
  6. Based on Trailing EPS.
  7. Based on reported cash and cash equivalents at end and extracted from the latest results announcement (Full Year, Half Year or Interim), adjusted for the current number of shares.
  8. Rounded to the nearest thousand.
  9. Beta and R-Squared are calculated in relation to the market index (STI or KLCI) using the historical daily closing values of the stock and index as data points.

Total Shareholder Return

PeriodDividend ReceivedCapital AppreciationTotal Shareholder Return
Short Term Return 5 Days ---
10 Days ---
20 Days ---
Medium Term Return 3 Months --0.010
-1.64 %
6 Months 0.025+0.060
+15.74 %
1 Year 0.030+0.200
+57.50 %
Long Term Return 2 Years 0.052-0.200
-18.50 %
3 Years 0.074-0.120
-6.39 %
5 Years 0.116-0.145
-3.89 %
Annualised Return Annualised --
-0.79 %
Notes:
  1. Total Shareholder Return (TSR) combines share price appreciation and dividends paid to show the total return to the shareholder expressed as a percentage.
  2. Script dividends are ignored in this calculation.

Price Movements

1 Year Range 0.355 - 0.670 Change From 1 Year Low +0.245 % Change From 1 Year Low (%) +69.01
Change From 1 Year High -0.070 % Change From 1 Year High (%) -10.45
2 Years Range 0.355 - 0.800 Change From 2 Years Low +0.245 % Change From 2 Years Low (%) +69.01
Change From 2 Years High -0.200 % Change From 2 Years High (%) -25.00
5 Years Range 0.355 - 0.920 Change From 5 Years Low +0.245 % Change From 5 Years Low (%) +69.01
Change From 5 Years High -0.320 % Change From 5 Years High (%) -34.78
Notes:
  1. Price movements are based on adjusted historical data.

Company Background

The Company was incorporated in Singapore on 10 April 1993 under the name of Videlli Pte Ltd which was subsequently changed to Eu Yan Sang International Holdings Pte Ltd on 1 September 1993. On 6 July 2000, it was converted into a public company and adopted its present name.The principal activities of the Company are investment holding and the provision of management services to the Group. Today, EYS manufactures and markets fine quality, Chinese herbs, Chinese Proprietary Medicines as well as health foods. EYS currently offers more than 250 products under its “Eu Yan Sang” brand name and over 1,000 different types ofChinese herbs and other medicinal products. Manufacturing facilities are carried out in its three GMP-certified (Good Manufacturing Practice) factories in Hong Kong and Malaysia.EYS's distribution network comprising of over 90 retail outlets in Hong Kong, Malaysia, Singapore and USA. “Eu Yan Sang” products are available in over 6,000 drugstores, pharmacies, medical halls, hospitals, supermarkets, chain stores, health clubs, spas and convenience stores worldwide. Its cybershop at www.euyansang.com.sg offers its global customers the ease and convenience of purchasing online.In addition, EYS operates a chain of 13 TCM clinics in Singapore and Malaysia; 3 Specialist TCM clinics in Singapore; 4 “YourHealth” Integrative Medicine Centres (IMC) in Australia. The Specialist TCM clinics and IMCs combine the best practices of conventional medicine, TCM and other natural therapies, providing modern consumers with a holistic approach to healthcare.

IPO Performance

Listing Date 28 Jul 2000 Full Subscription Rate (x) 2.05
No of Placement Shares (M) 64.30 No of Public Offer Shares (M) 7.20 Public Offer Subscription Rate (x) 11.40
IPO Price (SGD) a 0.199 First Day Close (SGD) a 0.176 First Week Close (SGD) a 0.142
Current vs IPO Price (%) +201.51 First Day Gain (%) -11.56 First Week Gain (%) -28.64
Notes:
  1. Adjusted for the following: Bonus Issue 1 for 4 on 07/11/2005, Special Dividend $0.015 on 04/11/2010, Bonus Issue 1 for 5 on 22/11/2010, Special Dividend $0.012 on 04/11/2011, Special Dividend $0.01 on 06/11/2012

Reports Download

Report Type Financial Year Ended Download
Annual Report
Annual Report 2015 Jun 2015 Part 1(0.86 MB)
Part 2(0.59 MB)
Part 3(0.04 MB)
Annual Report 2014 Jun 2014 Part 1(1.96 MB)
Part 2(0.27 MB)
Annual Report 2013 Jun 2013 Part 1(5.09 MB)
Annual Report 2012 Jun 2012 Part 1(4.01 MB)
Annual Report 2011 Jun 2011 Part 1(2.25 MB)
Annual Report 2010 Jun 2010 Part 1(4.04 MB)
Annual Report 2009 Jun 2009 Part 1(5.10 MB)
Annual Report 2008 Jun 2008 Part 1(0.97 MB)
Annual Report 2007 Jun 2007 Part 1(1.18 MB)
Part 2(0.34 MB)
Annual Report 2006 Jun 2006 Part 1(6.91 MB)
Annual Report 2005 Jun 2005 Part 1(2.64 MB)
IPO Prospectus
IPO Prospectus 2000 Jul 2000 Part 1(0.91 MB)

More Information Available

More information is available to our subscribers, including:

  • Market Moving News from Dow Jones Newswires
  • Consensus Estimates
  • Dividend/Distribution History
  • Financial Summary with Financial Period Comparison
  • Comprehensive Financial Ratios(ROA, ROE, Price/Revenue, Net Earnings Margin, Current Ratio, Debt to Equity Ratio etc)
  • Events Calendar for Results Announcements, Ex-Dates etc
  • Insider Buying and Selling Report

If you are an existing subscriber, please login. If not, read up on what you are missing out in our Help Centre and join us as a subscriber.

Disclaimer:

While reasonable efforts have been taken to ensure that the calculations performed by the features of this site are reliable, the features are provided on the basis that:-

  1. no liability is accepted for any errors or inaccuracies resulting from your use of these features;
  2. many of the data inputs (including share prices) are obtained from third party sources for which we assume no responsibility.